Notice of Special Interest (NOSI): Administrative Supplement for Providing Travel Support for Awardees to Attend the Annual NIH Synthetic Biology Consortium Meeting (Admin Supp)
Notice Number:
NOT-EB-20-022

Key Dates

Release Date:

November 10, 2020

First Available Due Date:
September 01, 2021
Expiration Date:
September 30, 2022

Related Announcements

PA-20-272 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

NOT-EB-20-017 - Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) announces the availability of Administrative Supplements to provide travel support for awardees of the Synthetic Biology for Biomedical Applications Notice (NOT-EB-20-017) to attend the annual NIH Synthetic Biology Consortium Meeting (eligible applicants are those who have received an award made in response to NOT-EB-20-017).

The administrative supplement application should justify the funds needed for the principal investigator(s) and the appropriate project members, including at least one trainee, to attend the annual NIH Synthetic Biology Consortium Meeting. The principal investigator(s) and other identified appropriate project members will be required to attend the annual NIH Synthetic Biology Consortium Meeting, either in-person or through a virtual conferencing service if necessary.

Application and Submission Information

This notice applies to due dates on or after January 19, 2021 and subsequent receipt dates through January 18, 2024.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.

  • PA-20-272 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and the funding opportunity announcement used for submission must be followed, with the following additions:

  • For funding consideration, applicants must include “NOT-EB-20-022” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.

Inquiries

Scientific/Research Contact(s)

David Rampulla
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4778
Email: david.rampulla@nih.gov

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

Financial/Grants Management Contact(s)

Ruthann McAndrew
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8521
Email: Ruthann.mcandrew@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices